CRO Biomapas is a privately owned contract research organization (CRO), established in 2001 - the first in Lithuania to conduct clinical trials. From the very start, the Company has been actively cooperating with the Kaunas University of Medicine, University Clinics and other Lithuanian medical institutions. Thus, CRO Biomapas assures a highly professional, scientific completion of all projects. CRO Biomapas has gained solid experience in various fields of medicine and capability for conducting Phase I-IV clinical trials for pharmaceutical and biotechnology industries. The data of the State Medicines Control Agency (SMCA) of Lithuania confirms that CRO Biomapas is a leading Lithuanian enterprise by the number of conducted clinical trials.
The Company is strategically located in Kaunas (Lithuania) with access to patient populations in all the Baltic States and Belarus, a region with a population of over 17 million inhabitants.
CRO Biomapas is proud to be working successfully with a number of renowned global pharmaceutical companies. Currently, the Company conducts the majority of its research projects in Lithuania. The strategic development, however, is targeted to serve in all three Baltic States and Belarus. Additionally, CRO Biomapas is ready to handle projects in Russia and Ukraine due to its in-depth knowledge and extensive contacts in the post-Soviet area.
CRO Biomapas is designed to offer full essential services to facilitate drug development. Services start from the early phase of clinical trials to ultimate market introduction of a medicinal product, complete with post-marketing surveillance and pharmacovigilance activities. Pricing and timing must be optimal - that is the Company objective. The Company has streamlined its structure and operations to achieve optimal services with excellence.
CRO Biomapas structures its work by the following Units:
- Clinical Research Unit
- Phase I Unit
- Data Management Unit
- Biostatistic Unit
- Medical Writing Unit
- Quality Assurance Unit
Currently, CRO Biomapas employs a full-time staff of 15 highly motivated, reliable, and flexible experts - experienced medical doctors, pharmacists, IT specialists, statisticians and others. External expertise is hired relevant to the requirements of any specific project. The Company policy encourages all employees to continuously advance in their professional fields. As many as three CRO Biomapas employees have Ph.D. degree. The specialists are the major assets of CRO Biomapas, fully capable of providing full satisfaction in Company’s services to all current and potential sponsors.
Key client benefits include:
- Capability to produce reliable clinical research data
- Competitive costs
- Wide range of services for Phase I-IV clinical trials
- Comprehensive Phase I Facility
- Geographical coverage with a population of 17 million or more
- Strong expertise in drug development and regulatory aspects in the region covered
- Dedicated and experienced staff
- Full service in data management (using Clintrial) and biostatistics (using SAS)
CRO Biomapas has proven these advantages by the successful accomplishment of its projects, greatly valued by our Sponsors.